+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-Thrombin III Testing Market by Product, Assay Type, End User, Application - Global Forecast to 2030- Product Image
Anti-Thrombin III Testing Market by Product, Assay Type, End User, Application - Global Forecast to 2030- Product Image
Sale

Anti-Thrombin III Testing Market by Product, Assay Type, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015079
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anti-thrombin III testing market is positioned as a crucial component within hemostasis and thrombosis diagnostics, rapidly evolving to address the growing complexities of coagulation disorders. This report offers senior decision-makers actionable insight into the market's structure, strategies, and emerging trends, empowering proactive planning and stakeholder alignment.

Market Snapshot: Anti-Thrombin III Testing Market

The Anti-Thrombin III Testing Market grew from USD 99.84 million in 2024 to USD 109.43 million in 2025. It is expected to continue growing at a CAGR of 9.43%, reaching USD 171.53 million by 2030. This growth reflects the increased clinical recognition of anti-thrombin III’s role in assessing blood coagulation status and the accelerating demand for reliable diagnostic solutions across global healthcare networks.

Scope & Segmentation

This report provides a comprehensive breakdown of the anti-thrombin III testing market, enabling strategic planning across multiple operational layers.

  • Product Categories: Instruments (automated, manual, semi-automated), reagents (consumables and kits), software, and supporting services (maintenance, training).
  • Assay Types: Chromogenic assays, clot-based assays (automated and manual clotting tests), and immunoassays (CLIA and ELISA platforms).
  • End User Segments: Diagnostic centers (including independent labs and private clinics), hospitals (secondary and tertiary care), and research institutes (academia, pharmaceutical organizations).
  • Application Areas: Clinical diagnostics (such as cardiovascular disease, disseminated intravascular coagulation, venous thromboembolism), genetic studies, and pharmacological research.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Italy, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, among others).
  • Key Market Participants: Companies such as F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Danaher Corporation, Instrumentation Laboratory Company, Sysmex Corporation, Thermo Fisher Scientific Inc., Helena Laboratories Corporation, Bio-Rad Laboratories, Inc., and Hyphen BioMed SAS.

Using Anti-Thrombin III Testing Technology

Automated instrumentation and integrated software platforms are increasingly foundational, driving improved test throughput and diagnostic reliability. The adoption of multiplexed assays serves both clinical and research needs, reflecting the ongoing trend toward comprehensive coagulation profiling. Regional infrastructure disparities influence the balance between centralized testing in mature markets and flexible, semi-automated solutions in developing regions.

Key Takeaways for Senior Decision-Makers

  • Refining anti-thrombin III assay protocols enhances patient management and reduces thrombotic event risk, boosting clinical adoption rates.
  • Next-generation automation enables laboratories to accommodate rising sample volumes while minimizing manual intervention and operational inefficiencies.
  • Standardization of regulatory frameworks worldwide prompts vendors to invest in validated, high-sensitivity platforms that support traceable, quality-assured results.
  • Shift toward value-based reimbursement drives the need for diagnostic providers to demonstrate tangible clinical utility through robust outcome data.
  • Collaboration between diagnostic manufacturers, software developers, and reference labs is becoming essential to deliver integrated digital health services and optimize care delivery.
  • Personalized medicine is fueling demand for advanced testing panels, providing tailored anticoagulation insights at both the routine and investigational level.

Tariff Impact: United States 2025 Adjustments

Forthcoming tariff adjustments in the United States for 2025 are reshaping cost structures in anti-thrombin III testing. Duties on imported reagents and specialized instruments have increased acquisition costs, pressuring suppliers to rethink pricing and supply strategies. In response, manufacturers are expediting localization initiatives and sourcing alternatives to stabilize supply chains. Service agreements increasingly favor fixed-price and long-term commitments to navigate regulatory unpredictability, while laboratories consider in-house kit production and open-platform methods to sustain operations.

Methodology & Data Sources

This analysis combines secondary research, including industry literature and regulatory filings, with primary interviews from laboratory directors, key opinion leaders, and commercial procurement experts. Rigorous segmentation and data triangulation were used to cross-verify trends across products, end users, and geographies, with sensitivity analyses addressing data consistency challenges. All methodological limitations were managed through expert validation and ongoing quality reviews.

Why This Report Matters

  • Enables executive teams to formulate evidence-based strategies for product development, market expansion, and operational efficiency in a dynamic diagnostic environment.
  • Offers granular insight into technology trends, regulatory changes, and competitive dynamics, informing both short- and long-term investment planning.

Conclusion

The anti-thrombin III testing market is in transition, marked by innovation, shifting regulations, and evolving adoption drivers. Strategic alignment with these dynamics positions stakeholders to capture value, drive improved patient outcomes, and sustain growth in a competitive landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anti-Thrombin III Testing Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Automated
8.2.2. Manual
8.2.3. Semi Automated
8.3. Reagents
8.3.1. Consumables
8.3.2. Kits
8.4. Software And Services
8.4.1. Services
8.4.1.1. Maintenance
8.4.1.2. Training
8.4.2. Software
9. Anti-Thrombin III Testing Market, by Assay Type
9.1. Introduction
9.2. Chromogenic Assay
9.3. Clot-Based Assay
9.3.1. Automated Clotting Test
9.3.2. Manual Clotting Test
9.4. Immunoassay
9.4.1. Clia
9.4.2. Elisa
10. Anti-Thrombin III Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.2.1. Independent Labs
10.2.2. Private Clinics
10.3. Hospitals
10.3.1. Secondary Care
10.3.2. Tertiary Care
10.4. Research Institutes
10.4.1. Academia
10.4.2. Pharmaceutical
11. Anti-Thrombin III Testing Market, by Application
11.1. Introduction
11.2. Clinical Diagnosis
11.2.1. Cardiovascular Diseases
11.2.2. Disseminated Intravascular Coagulation
11.2.3. Venous Thromboembolism
11.3. Research
11.3.1. Genetic Studies
11.3.2. Pharmacological Research
12. Americas Anti-Thrombin III Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anti-Thrombin III Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anti-Thrombin III Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche Ltd
15.3.2. Siemens Healthineers AG
15.3.3. Abbott Laboratories
15.3.4. Danaher Corporation
15.3.5. Instrumentation Laboratory Company
15.3.6. Sysmex Corporation
15.3.7. Thermo Fisher Scientific Inc.
15.3.8. Helena Laboratories Corporation
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. Hyphen BioMed SAS
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTI-THROMBIN III TESTING MARKET MULTI-CURRENCY
FIGURE 2. ANTI-THROMBIN III TESTING MARKET MULTI-LANGUAGE
FIGURE 3. ANTI-THROMBIN III TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTI-THROMBIN III TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTI-THROMBIN III TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTI-THROMBIN III TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TRAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AUTOMATED CLOTTING TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY MANUAL CLOTTING TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY GENETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PHARMACOLOGICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 90. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 91. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 92. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 95. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 96. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 98. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 99. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 100. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 102. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 103. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 107. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 115. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 187. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 194. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 199. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 201. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 224. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 227. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 228. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 230. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 231. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 232. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 234. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 236. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 238. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 239. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 241. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 242. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 243. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 244. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 246. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 253. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 299. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 302. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 303. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 304. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 305. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 306. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 307. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 310. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 311. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 313. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY CLOT-BASED ASSAY, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS ANTI-THROMBIN I

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anti-Thrombin III Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Instrumentation Laboratory Company
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Helena Laboratories Corporation
  • Bio-Rad Laboratories, Inc.
  • Hyphen BioMed SAS

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 109.43 Million
Forecasted Market Value ( USD ) by 2030 $ 171.53 Million
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anti-thrombin III Testing Market 2024-2028 - Product Image

Anti-thrombin III Testing Market 2024-2028

  • Report
  • 153 Pages
  • Global
From
2024-2029 Global Coagulation Market-Growth Opportunities and Strategies for Hemostasis Analyzers and Reagents-US, Europe, Japan-Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation - Product Image

2024-2029 Global Coagulation Market-Growth Opportunities and Strategies for Hemostasis Analyzers and Reagents-US, Europe, Japan-Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation

  • Report
  • Europe, Global
From
2025 France Hemostasis Analyzers, Reagents - Competitive Shares and Strategies, Volume and Sales Segment Forecasts for Chromogenic, Immunodiagnostic and Molecular Coagulation Tests - Emerging Technologies, Opportunities - Product Image

2025 France Hemostasis Analyzers, Reagents - Competitive Shares and Strategies, Volume and Sales Segment Forecasts for Chromogenic, Immunodiagnostic and Molecular Coagulation Tests - Emerging Technologies, Opportunities

  • Report
  • France
From
Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030 - Product Image

Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Coagulation Testing Market by Product, by Test, by Technology. by Application, by End-user, and by Region - Product Image

Coagulation Testing Market by Product, by Test, by Technology. by Application, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.